睿智医药(300149.SZ)：子公司拟与专业投资机构共同投资合伙企业

Group 1 - The core point of the article is that Ruizhi Pharmaceutical (300149.SZ) has signed a partnership agreement to establish a new investment fund focused on the healthcare industry, particularly innovative drugs and medical devices [1] - The total committed capital for the partnership is RMB 200 million, with Beihai Ruizhi contributing RMB 58 million, representing 29% of the total [1] - The partnership involves collaboration with Shenzhen Investment Control Donghai Investment Co., Ltd. and other limited partners, indicating a strategic move to enhance investment capabilities in the healthcare sector [1] Group 2 - The newly established fund, tentatively named Shenzhen Luohu Donghai Ruizhi Pharmaceutical Industry Partnership (Limited Partnership), aims to invest primarily in innovative drugs [1] - The involvement of professional investment institutions suggests a structured approach to capital allocation in the healthcare market [1] - This initiative reflects a growing trend in the pharmaceutical industry towards investment in innovation and technology-driven healthcare solutions [1]